Gonococcal Isolate Surveillance Project

ICR 201805-0920-005

OMB: 0920-0307

Federal Form Document

Forms and Documents
Document
Name
Status
Form
Modified
Form
New
Form
Modified
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supplementary Document
2018-07-20
Supporting Statement B
2018-07-20
Supporting Statement A
2018-07-20
ICR Details
0920-0307 201805-0920-005
Active 201512-0920-005
HHS/CDC
Gonococcal Isolate Surveillance Project
Revision of a currently approved collection   No
Regular
Approved without change 08/20/2018
Retrieve Notice of Action (NOA) 07/20/2018
  Inventory as of this Action Requested Previously Approved
08/31/2021 36 Months From Approved 02/28/2019
26,592 0 14,700
11,376 0 8,628
226,117 0 0

The purpose of these forms is to continue to collect surveillance data on antimicrobial resistance in Neisseria gonorrhoeae. These data are used by public health officials at the national, state, and local level to determine appropriate therapy for gonorrhea. In addition, the data are used to monitor trends N. gonorrhoeae antimicrobial resistance and certain epidemiologic aspects of gonorrhea.

US Code: 42 USC 301 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  83 FR 5102 02/05/2018
83 FR 34583 07/20/2018
Yes

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 26,592 14,700 0 11,892 0 0
Annual Time Burden (Hours) 11,376 8,628 0 2,748 0 0
Annual Cost Burden (Dollars) 226,117 0 0 226,117 0 0
Yes
Miscellaneous Actions
Yes
Miscellaneous Actions
There is no change in burden for 20 sentinel sites that will continue to conduct core surveillance. There is an increase in burden for 10 sentinel sites that will begin collecting additional data and specimens for enhanced surveillance. Enhanced surveillance will increase the number of isolates submitted for antimicrobial resistance testing. Measures have been taken to decrease the burden per response, but there is a net increase in burden. There is a decrease in burden associated with control strain susceptibility testing.

$1,176,900
Yes Part B of Supporting Statement
    Yes
    No
No
No
No
Uncollected
Renita Macaluso 770 488-6458 arp5@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/20/2018


© 2024 OMB.report | Privacy Policy